Clinical Trial Update: Transversus Abdominis Plane (TAP) Block Using Liposomal Bupivacaine in Metabolic and Bariatric Surgery Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating transversus abdominis plane (TAP) blocks with liposomal bupivacaine in morbid obesity patients undergoing bariatric surgery; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity

Drugs mentioned

• Exparel (bupivacaine liposomal) (bupivacaine liposomal)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Morbid Obesity, Bariatric Surgery Candidate | Phase 1 | Status: COMPLETED | Results posted: 2025-06-11